Literature DB >> 8381794

Typing of human papillomavirus DNAs by restriction endonuclease mapping of the PCR products.

M Contorni1, P Leoncini.   

Abstract

The polymerase chain reaction (PCR) for the diagnosis of human papillomavirus (HPV) infections, and in particular for the study of cervical HPV-associated lesions, is used widely. We identified a novel set of universal primers that are able to amplify a fragment spanning the E1 open reading frame (ORF) from different mucosotropic HPV types. A restriction endonuclease digestion of the amplified products is suggested for accurate typing. In particular, AluI digestion of the amplified fragments yields a distinctive fragment pattern for each 'high-risk' (16, 18, 31 and 33) HPV sequence, thus distinguishing them from 'low-risk' (6b and 11) HPV sequences.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381794     DOI: 10.1016/0166-0934(93)90160-s

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  4 in total

1.  Known HPV types have no association with keratoacanthomas.

Authors:  S Lu; S L Syrjänen; V K Havu; S Syrjänen
Journal:  Arch Dermatol Res       Date:  1996-03       Impact factor: 3.017

2.  Evaluation of immunoassays for the detection and typing of PCR amplified human papillomavirus DNA.

Authors:  S Venturoli; M Zerbini; M La Placa; A D'Antuono; M Negosanti; G Gentilomi; G Gallinella; E Manaresi; M Musiani
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

3.  Detection and typing of human papillomavirus by e6 nested multiplex PCR.

Authors:  K Sotlar; D Diemer; A Dethleffs; Y Hack; A Stubner; N Vollmer; S Menton; M Menton; K Dietz; D Wallwiener; R Kandolf; B Bültmann
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

4.  Human papillomavirus in vulvar and vaginal carcinoma cell lines.

Authors:  S Hietanen; S Grénman; K Syrjänen; K Lappalainen; J Kauppinen; T Carey; S Syrjänen
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.